VR Logo

Fredun Pharmaceuticals Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1987

Chairman: Daulat N Medhora

Managing Director: Fredun N Medhora

Group: --

Listing: BSE: 539730

Headquarters: Mumbai, Maharashtra

Website: www.fredungroup.com

Key Facts

Market cap: R 69.76 Cr

Revenue (TTM): R 120.29 Cr

Earnings (TTM): R 3.25 Cr

Cash: R 1.47 Cr

Total Debt: R 9.69 Cr

Promoters' ownership: 52.04%

Liquidity: Moderate

52 Week range: R 103.00 - 443.95

Face value: R10.00

Shares outstanding: 39,89,634

10 Years Aggregate:

  • CFO: 19.54 Cr
  • EBITDA: 28.94 Cr
  • Net Profit: 9.07 Cr

Stock Performance

Time Period Fredun Pharmaceuticals S&P BSE Healthcare* S&P BSE Small Cap*
YTD-22.3923.40-6.54
1 month-7.901.467.10
3 months11.1213.8624.38
1 Year-54.6829.91-6.53
3 Years--4.43-6.96
5 Years---0.572.46
10 Years--11.153.28
As on 13-Jul-2020 *As on 10-Jul-2020
Year Fredun Pharmaceuticals S&P BSE Small Cap S&P BSE Healthcare
2019-34.29-6.85-3.55
2018220.13-23.41-5.89
2017124.5259.640.49